Brief: Baxter and Scinopharm announce partnership for generic oncology injectables
28/02/2017 13:00
Feb 28 (Reuters) - Baxter International Inc BAX.N
* Baxter and Scinopharm announce exclusive strategic
partnership for generic oncology injectables
* Baxter International Inc - under terms of partnership,
Baxter and Scinopharm will collaborate on product development
and manufacturing
* Baxter International Inc - Baxter will hold
commercialization rights, with products included in arrangement
expected to launch beginning in 2020
Source text for Eikon: ID:nBw56lC2ta
Further company coverage: BAX.N
((Bangalore.newsroom@thomsonreuters.com;))